With Evo 2, researchers can rapidly predict protein structures and generate DNA sequences, significantly advancing the fields ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...